SAKAR HEALTHCARE:
Q3 SL NET PROFIT 102M RUPEES VS 45M (YOY)
SAKAR HEALTHCARE: Q3 EBITDA 186M RUPEES VS 118M (YOY) || Q3 EBITDA MARGIN 26.4% VS 27.1% (YOY)
SAKAR
#WatchOutFor#StockInNews
887 likes·46 comments
Popular topics to explore
Q3 SL NET PROFIT 102M RUPEES VS 45M (YOY)
SAKAR HEALTHCARE: Q3 EBITDA 186M RUPEES VS 118M (YOY) || Q3 EBITDA MARGIN 26.4% VS 27.1% (YOY)
SAKAR